Enzymes for Research, Diagnostic and Industrial Use
Our Products Cannot Be Used As Medicines Directly For Personal Use.
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
| Catalog | Product Name | EC No. | CAS No. | Source | Price |
|---|---|---|---|---|---|
| NATE-1605 | Native Snake Venom Carinactivase | Snake Venom | Inquiry |
Carinactivase is a promising enzyme with great potential in several areas of biotechnology and medicine. Its unique properties and its ability to selectively cleave proteins open up new possibilities for protein engineering, drug discovery and targeted therapy. Despite the challenges, ongoing research efforts are expected to overcome these obstacles and realize the full potential of carinactivase. Discovering and utilizing carinactivase will bring us closer to realizing the future of precision medicine and advanced biotechnology applications.
Carinactivase is a relatively large enzyme consisting of a primary structure folded into a specific three-dimensional configuration. It consists of multiple structural domains that are distinct regions of the enzyme with different functions. The arrangement and interaction of these structural domains contributes to the overall stability and catalytic activity of Caine-activated enzyme.
The catalytic structural domain of Caine-activating enzyme is one of the key components that determine its enzymatic activity. This structural domain contains the active site for peptide bond cleavage. The active site consists of a specific arrangement of amino acids, including residues necessary for substrate recognition and catalysis.
Like many other proteins, carinactivase undergo post-translational modifications (PTM). These modifications include processes such as glycosylation, phosphorylation, acetylation, etc. PTMs can affect the structure, stability, localization, and activity of carinactivase, further diversifying its function and activity.
Despite the immense potential of carinactivase, certain challenges must be addressed for its widespread adoption. These include large-scale production, purification methods, and potential off-target effects. Researchers are actively working to overcome these obstacles, employing techniques such as protein engineering and optimization of expression systems. The future prospects of carinactivase lie in expanding its applications through synergistic collaborations, enhancing its stability, and developing novel delivery systems.
Carinactivase exhibits significant clinical significance in areas such as cancer treatment and infectious diseases. Its ability to selectively degrade disease-associated proteins provides opportunities for designing personalized therapies. Furthermore, carinactivase-based drug delivery systems can enhance the efficacy and selectivity of therapeutic agents, minimizing side effects and improving patient outcomes.
The versatility of carinactivase positions it for numerous applications, notably in the fields of biotechnology and medicine. In biotechnology, carinactivase is utilized for protein purification, proteomics research, and enzymatic modifications of proteins. Moreover, its high catalytic efficiency makes it an excellent candidate for industrial processes requiring selective peptide bond cleavage. In medicine, carinactivase shows promise in the development of novel therapeutic strategies, including targeted protein degradation and drug delivery systems.
Carinactivase is a promising enzyme with great potential in several areas of biotechnology and medicine. Its unique properties and its ability to selectively cleave proteins open up new possibilities for protein engineering, drug discovery, and targeted therapy. Despite the challenges, ongoing research efforts are expected to overcome these obstacles and realize the full potential of carinactivase. Discovering and utilizing carinactivase will bring us closer to realizing the future of precision medicine and advanced biotechnology applications.
